Mycophenolic acid
- Generic Name
- Mycophenolic acid
- Brand Names
- Myfortic
- Drug Type
- Small Molecule
- Chemical Formula
- C17H20O6
- CAS Number
- 24280-93-1
- Unique Ingredient Identifier
- HU9DX48N0T
- Background
Mycophenolic acid is a potent immunosuppressant agent that inhibits de novo purine biosynthesis. It was derived from Penicillium stoloniferum, and has also shown antibacterial, antifungal and antiviral properties.. Mycophenolic acid is used in immunosuppressive regimens as part of a triple therapy that includes a calcineurin inhibitor (ciclosporin or tacroli...
- Indication
Mycophenolic acid is an antimetabolite immunosuppressant indicated for prophylaxis of organ rejection in adult patients receiving kidney transplants and in pediatric patients at least 5 years of age and older who are at least 6 months post kidney transplant. Mycophenolic acid is used in combination with cyclosporine and corticosteroids.
- Associated Conditions
- Kidney Transplant Rejection
- Associated Therapies
- -
Freedom Study: Myfortic in Kidney Transplant Patients
- Conditions
- First Posted Date
- 2005-01-13
- Last Posted Date
- 2011-01-31
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 342
- Registration Number
- NCT00101738
- Locations
- 🇬🇧
Queen Elizabeth Medical Centre, Edgbaston, Birmingham, United Kingdom
🇦🇺Royal Melbourne Hospital, Parkville, Victoria, Australia
🇬🇧Walsgrave Hospital NHS Trust, Walsgrave, Coventry, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.